Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy.

  • Offers the views of experts on current advances in the field of hematologic malignancy
  • Gathers and highlights important recent papers from a wealth of original publications
  • Draws on the expertise of authorities in 12 related subject areas

Journal information

Editor-in-Chief
  • Ruben A. Mesa
Publishing model
Hybrid. Open Access options available

Journal metrics

2.531 (2019)
Impact factor
2.242 (2019)
Five year impact factor
85,671 (2019)
Downloads

Latest articles

This journal has 33 open access articles

Subscribe

eJournal
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
1558-822X
Print ISSN
1558-8211
Abstracted and indexed in
  1. CNKI
  2. Current Contents/Clinical Medicine
  3. Dimensions
  4. EBSCO Biomedical Reference Collection
  5. EBSCO Discovery Service
  6. EMBASE
  7. Google Scholar
  8. Institute of Scientific and Technical Information of China
  9. Japanese Science and Technology Agency (JST)
  10. Journal Citation Reports/Science Edition
  11. Medline
  12. Naver
  13. OCLC WorldCat Discovery Service
  14. ProQuest-ExLibris Primo
  15. ProQuest-ExLibris Summon
  16. Reaxys
  17. SCImago
  18. SCOPUS
  19. Science Citation Index Expanded (SciSearch)
  20. Semantic Scholar
  21. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature